FDA fires broadside at unscrupulous stem cell therapy actors

US Food and Drug Administration (FDA) Commissioner Scott Gottlieb has hit out against false prophets and dangerous players in the much-hyped world of stem cell therapies and their use in regenerative medicine as he outlined plans for a new comprehensive policy framework.

Accepting the undoubted potential of this field to deliver transformative and potentially curative treatments for some of humanity’s most troubling and intractable maladies including cancer, Parkinson’s disease and diabetes, Dr Gottlieb has warned that the novelty and uncertainty associated with the research has also brought a negative impact.

"Products that are reliably and carefully developed will be harder to advance if bad actors are able to make hollow claims and market unsafe science"